BRIDGEWATER, N.J. & FORT WORTH, Texas--(BUSINESS WIRE)--Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed. The company also announced that its new name is Adare Pharmaceuticals and John Fraher, ...